Skip to main content
Clinical Trials/JPRN-jRCTs031190226
JPRN-jRCTs031190226CompletedPhase 2

A prospective multi-center open trial to evaluate the safety and efficacy of favipiravir in patients infected with COVID-19.

Tokue Yutaka0 sites100 target enrollmentStarted: February 27, 2020Last updated:

Trial Snapshot

Phase
Phase 2
Status
Completed
Sponsor
Enrollment
100

Study Overview

Brief Summary

There was no difference in adjusted mean change in CRP between cohorts 1 and 2: -1.57 (95% CI -3.02 to -0.12) mg/dL and -2.29 (95% CI -3.77 to -0.81) mg/dL, respectively (p=0.500). The negative conversion rate of SARS-CoV-2 was higher in cohort 2 than in cohort 1 (odds ratio 2.67 (95% CI, 1.09 to 6.52), p=0.032), and a trend of greater efficacy was seen in patients with older age, lower BMI, lower baseline CRP, and without steroid use.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
>= 20age old to ot applicable (—)
Sex
All

Inclusion Criteria

  • positive result for COVID-19 detection test
  • fever above 37.5 degree Celsius, or pneumonia shadow on chest X-ray or CT-scan
  • hospital admission

Exclusion Criteria

  • Not provided

Investigators

Sponsor
Tokue Yutaka

Similar Trials

Completed
Phase 3
hATG+CsA vs hATG+CsA+Eltrombopag for SAASevere Aplastic Anemia
NCT02099747European Society for Blood and Marrow Transplantation202
Completed
Not Applicable
A prospective randomized, multicenter trial evaluating the efficacy and safety of combined therapy with pirfenidone and inhaled N-acetylcysteine for idiopathic pulmonary fibrosis.Idiopathic pulmonary fibrosis
JPRN-UMIN000015508Grant for Research on Diffuse Lung Disease from the Ministry of Health, Labour and Welfare of Japan.81
Completed
Not Applicable
A multi-center, randomized, parallel-group study to assess the changes in macular pigment density and visual performance in the patients with age-related macular degeneration, who received a lutein supplementPatients with hemilateral age-related macular degeneration (AMD)
JPRN-UMIN000007628Seirei Hamamatsu General Hospital84
Recruiting
Not Applicable
Comparative study between Diode Laser Surgery and Filtering Surgery as a Primary Surgical Procedure for patients with GlaucomaOpen Angle GlaucomaC11.525.381C11.525.381.407
RBR-65rzrvCentro de Referência em Oftalmologia da Universidade Federal de Goiás (CEROF-UFG)
Active, not recruiting
Not Applicable
A trial in which will be studied if the addition of a medicine that is used for improving platelet counts (eltrombopag) to the regular treatment for aplastic anemia (hATG + CsA) also improves the numbers of other cell lines and therefore the overall bone marrow function.Idiopathic (Severe) Aplastic Anemia, a bone marrow failure syndrome which results in the normal hematopoietic tissue completely missing from the bone marrow, accounting for the subsequent pancytopenia.MedDRA version: 18.0Level: PTClassification code 10002967Term: Aplastic anaemiaSystem Organ Class: 10005329 - Blood and lymphatic system disorders
EUCTR2014-000363-40-ESEuropean Society for Blood and Marrow Transplantation200